AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionLifeworks Advisors, LLC
Latest Disclosed Ownership39,697 shares
Latest Disclosed Value $ 8,633,790
Lifeworks Advisors, LLC reports 6.54% increase in ownership of ABBV / AbbVie Inc.

On May 4, 2026 - Lifeworks Advisors, LLC filed a 13F-HR form disclosing ownership of 39,697 shares of AbbVie Inc. (US:ABBV) valued at $8,633,701 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 37,261 shares of AbbVie Inc.. This represents a change in shares of 6.54% during the quarter. The current value of the position is $8,929,443 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F ABBVIE COM 00287Y109 39,697 2,436 6.54 8,634 1.41 1.1078
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 37,261 -6,837 -15.50 8,514 -16.62 1.1024
2025-11-12 2025-09-30 13F ABBVIE COM 00287Y109 44,098 -2,326 -5.01 10,210 18.49 1.3594
2025-08-05 2025-06-30 13F ABBVIE COM 00287Y109 46,424 1,575 3.51 8,617 -8.29 1.2849
2025-05-06 2025-03-31 13F ABBVIE COM 00287Y109 44,849 2,814 6.69 9,397 25.80 1.5616
2025-02-07 2024-12-31 13F ABBVIE COM 00287Y109 42,035 8,337 24.74 7,470 12.25 1.3480
2024-11-06 2024-09-30 13F ABBVIE COM 00287Y109 33,698 1,269 3.91 6,655 19.63 1.3082
2024-08-13 2024-06-30 13F ABBVIE COM 00287Y109 32,429 4,448 15.90 5,562 9.17 1.5490
2024-05-10 2024-03-31 13F ABBVIE COM 00287Y109 27,981 2,268 8.82 5,095 27.89 1.4262
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 25,713 482 1.91 3,985 5.96 1.3749
2023-11-01 2023-09-30 13F ABBVIE COM 00287Y109 25,231 940 3.87 3,761 14.91 1.4632
2023-08-02 2023-06-30 13F ABBVIE COM 00287Y109 24,291 3,911 19.19 3,273 0.77 1.3936
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 20,380 -325 -1.57 3,248 -2.96 1.5337
2023-02-14 2022-12-31 13F ABBVIE COM 00287Y109 20,705 97 0.47 3,346 10.90 1.8846
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 20,608 -3,531 -14.63 3,017 -18.39 1.7166
2022-08-12 2022-06-30 13F ABBVIE COM 00287Y109 24,139 2,504 11.57 3,697 5.42 2.3438
2022-05-16 2022-03-31 13F ABBVIE COM 00287Y109 21,635 6,390 41.92 3,507 69.91 2.3160
2022-02-15 2021-12-31 13F ABBVIE COM 00287Y109 15,245 15,245 2,064 1.6442
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.